Effect of folic acid on hematological changes in methionine-induced hyperhomocysteinemia in rats

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 3, 2009, Pages 270-275

  Ansari, M N ^a   Nigam, G K ^a   Bhandari, Uma ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Folic acid; Hematological changes; Homocysteine; Methionine; Oxidative stress

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD SMEAR; CELL DAMAGE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; ERYTHROCYTE MEMBRANE; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HYPERHOMOCYSTEINEMIA; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LIPID ANALYSIS; LYMPHOCYTE COUNT; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; POLYMORPHONUCLEAR CELL; RAT; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 70349799245     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.56025     Document Type: Article

References (41)

1. NIH. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, 2002, NIH Publication No. 02-5215.
2. Malinow MR. Plasma homocyst(e)ine and arterial occlusive diseases: A mini-review. Clin Chem 1995;41:173-176
3. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Eng J Med 1995;332:286-291
4. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998;49:31-62.
5. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J Am Med Assoc 1998;279:359-364 (Pubitemid 28133864)
6. Stanger O, Semmelrock HJ, Wonisch W, Bos U, Pabst E, Wascher TC. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 2002;303:158-162
7. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 1996;98:5-7.
8. Parthasarathy S. Oxidation of low density lipoprotein by thiol compounds leads to the recognition by the acetyl LDL receptor. Biochim Biophy Acta 1987;917:337-340 (Pubitemid 17004984)
9. Harker LA, Slichter SJ, Scott CR, Ross R. Homocysteinemia: vascular injury and arterial thrombosis. N Engl J Med 1974;291:537-543
10. Starkebaum G, Harlan JM. Endothelial cell injury due to copper catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-1376
11. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, et al. Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-318
12. Hennig B, Toborek M, Alvarado Cader A, Decker E. Nutrition, endothelial cell metabolism, and atherosclerosis. Crit Rev Food Sci Nutr 1993;34:253-282
13. Yen CH, Lau YT. Vascular Responses in Male and Female Hypertensive Rats With Hyperhomocysteinemia. Hypertension 2002;40:322.
14. Klavins JV, Kinney TD. Histopathologic changes in methionine excess. Arch Pathol 1963;75:661-673
15. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine. Circulation 2002;105:22-26
16. Doshi SN, McDowell IFW, Moat SJ, Lang D, Newcombe RG, Kredean MB, et al. Folate improves endothelial function in coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21:1196-1202
17. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Int Med 2001;161:695-700.
18. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT. Low dietary folate intake is associated with an excess incidence of acute coronary events: The kuopio ischemic heart disease risk factor study. Circulation 2001;103:2674-2680 (Pubitemid 32538781)
19. Primus FJ, Kelley EA, Hansen HJ, Goldenberg DM. Sandwich-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem 1988;34:261-264
20. Burstein M, Scholnick MR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-586
21. Demacher PNM, Hijamaus AGM. A study of the use of polyethylene glycol in estimating cholesterol. Clin Chem 1980;26:1775-1778
22. Foster LB, Dunn RT. Stable reagents for the determination of serum triglycerides by a colorimetric Hantzch condensation method. J Clin Chem 1973;19:338-340
23. Dacie JV, Lewis SM. Practical haematology. Churchill Livingstone, London; 9th ed. 2001. p. 19-46.
24. Omenn GS, Beresford SAA, Motulsky AG. Preventing coronary heart disease: B vitamins and homocysteine. Circulation 1998;97:421-424
25. Stein JH, McBride PE. Hyperhomocystenemia and atherosclerotic vascular disease: pathophysiology, screening and treatment. Arch Intern Med 1998;158:1301-1306
26. McCully KS, Wilson RB. Homocyseine theory of arteriosclerosis. Atheroscler 1969;22:215-217
27. Faraci FM, Lentz SR. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004;35:345-347
28. Assanelli D, Bonamone A, Pezzini A, Albertini F, Maccali P, Grassi M, et al. Folic acid & Vitamin E supplementation effects on homocysteinemia, endothelial function & plasma antioxidant capacity in young myocardial-infarction patients. Pharmacol Res 2004;49:79-84.
29. Racek J, Rusnáková H, Trefil L, Siala KK. The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. Physiol Res 2005;54:87-95.
30. Toborek M, Kopieczna-Grzebieniak E, Drózdz M, Wieczorek M. Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits. Atherosclerosis 1995;115:217-224
31. Kapoor HK, Bhai S, John M, Xavier J. Ocular manifestations of dengue fever in an East Indian epidemic. Can J Ophthalmol 2006;41:741-746
32. Zulli A, Buxton B, Doolan L, Liu JJ. Effect of homocysteine and cholesterol in raising plasma homocysteine, cholesterol and triglyceride levels. Life Science 1998;62:2191-2194
33. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J 1998;316:894-898
34. Rydlewicz A, Simpson JA, Taylor RJ, Bond CM, Golden MHN. The effect of folic acid supplementation on plasma homocyteine in an elderly population. Quarterly J Med 2002;95:27-35.
35. Lamers Y, Prinz-Langenohl R, Moser R, Pietrzik K. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr 2004;79:473-478
36. Nicholas PB, Dubman T, Guo XW. Homocysteine enhances neutrophilendothelial interactions in both cultured human cells and rats in vivo. Circ Res 1999;84:409-416
37. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986;314:488-500.
38. Suzuki M, O'Neal RM. Circulating lipophages, serum lipids, and atherosclerosis in rats. Arch Pathol 1967;83:169-174
39. Suzuki M, O'Neal RM. Accumulation of lipids in leukocytes of rats fed atherogenic diets. J Lipid Res 1964;5:624-627
40. Bath PM, Gladwin AM, Martin JF. Human monocyte characteristics are altered in hypercholesterolemia. Atherosclerosis 1991;90:175-181
41. Benevenga NJ, Steele RD. Adverse effects of excessive consumption of amino acids. Ann Rev Nutr 1984;4:157-181